Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Athira Pharma Inc..
Athira Pharma Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Athira Pharma Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Athira Pharma Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Athira Pharma Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Athira Pharma Inc. and all latest updates of the company are provided.
The 2025 version of Athira Pharma Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Athira Pharma Inc.- Key Facts
2.2 Athira Pharma Inc.- Geographic Locations
2.3 Athira Pharma Inc.- Subsidiaries and Affiliates
2.4 Athira Pharma Inc.- Business Divisions
2.5 Athira Pharma Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Athira Pharma Inc. Strategic Analysis Review
3.1 Athira Pharma Inc.- Key Strategies
3.2 Athira Pharma Inc.- Company Outlook Statement
3.3 Athira Pharma Inc.- SWOT Analysis
3.3.1 Athira Pharma Inc.- Key Strengths
3.3.2 Athira Pharma Inc.- Key Weaknesses
3.3.3 Athira Pharma Inc.- Potential Opportunities
3.3.4 Athira Pharma Inc.- Potential Threats
3.4 Athira Pharma Inc.- Key Competitors
4. Business Description of the Company
4.1 Athira Pharma Inc.- Business Overview
4.2 Athira Pharma Inc.- Operations by Segment
5 Products and Services Details
5.1 Athira Pharma Inc.- Key Products
5.2 Athira Pharma Inc.- Key Service Areas
5.3 Athira Pharma Inc.- Key Brands
6 Company Developments
6.1 Athira Pharma Inc.- Company History
6.2 Athira Pharma Inc.- Latest Developments
7 Financial Analysis
7.1 Athira Pharma Inc.- Income Statements
7.2 Athira Pharma Inc.- Balance Sheet
7.3 Athira Pharma Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Athira Pharma Inc.- Direct Competitors
8.2 Athira Pharma Inc.- Competitor Financial Ratios comparison
8.3 Athira Pharma Inc.- Competitor Stock Charts Comparison
8.4 Athira Pharma Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
